X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (225) 225
life sciences & biomedicine (202) 202
humans (196) 196
oncology (116) 116
animals (101) 101
mutation (86) 86
lung neoplasms - drug therapy (79) 79
female (77) 77
mice (73) 73
cell line, tumor (69) 69
lung neoplasms - genetics (61) 61
carcinoma, non-small-cell lung - drug therapy (57) 57
male (55) 55
cell biology (54) 54
lung cancer (49) 49
carcinoma, non-small-cell lung - genetics (44) 44
middle aged (44) 44
protein kinase inhibitors - therapeutic use (44) 44
cancer (42) 42
protein kinase inhibitors - pharmacology (40) 40
biochemistry & molecular biology (38) 38
antineoplastic agents - therapeutic use (37) 37
human necessities (36) 36
hygiene (36) 36
medical or veterinary science (36) 36
preparations for medical, dental, or toilet purposes (36) 36
adult (35) 35
aged (35) 35
drug resistance, neoplasm - genetics (35) 35
research (35) 35
specific therapeutic activity of chemical compounds ormedicinal preparations (35) 35
lung neoplasms - pathology (32) 32
receptor, epidermal growth factor - antagonists & inhibitors (32) 32
receptor, epidermal growth factor - genetics (31) 31
antineoplastic agents - pharmacology (30) 30
lung neoplasms - metabolism (27) 27
phosphatidylinositol 3-kinases - metabolism (26) 26
respiratory tract diseases (25) 25
tumors (25) 25
drug resistance (24) 24
neoplasms (24) 24
care and treatment (23) 23
genetic aspects (23) 23
mice, nude (23) 23
signal transduction (23) 23
apoptosis (22) 22
carcinoma, non-small-cell lung - pathology (22) 22
multidisciplinary sciences (22) 22
science & technology - other topics (22) 22
drug resistance, neoplasm (21) 21
kinases (21) 21
phosphatidylinositol 3-kinases - genetics (21) 21
treatment outcome (21) 21
xenograft model antitumor assays (21) 21
phosphatidylinositol 3-kinases - antagonists & inhibitors (20) 20
receptor protein-tyrosine kinases - genetics (20) 20
signal transduction - drug effects (20) 20
aged, 80 and over (19) 19
apoptosis - drug effects (19) 19
medicine, research & experimental (19) 19
neoplasms - drug therapy (19) 19
research & experimental medicine (19) 19
carcinoma, non-small-cell lung - metabolism (18) 18
drug therapy (18) 18
pyridines - therapeutic use (18) 18
receptor, epidermal growth factor - metabolism (18) 18
health aspects (17) 17
proteins (17) 17
proto-oncogene proteins - genetics (17) 17
pyrazoles - therapeutic use (17) 17
caveolins (16) 16
drug resistance, neoplasm - drug effects (16) 16
quinazolines - pharmacology (16) 16
caveolin 1 (15) 15
gene expression (15) 15
neoplasms - genetics (15) 15
abridged index medicus (14) 14
adenocarcinoma - genetics (14) 14
cell proliferation - drug effects (14) 14
lung cancer, non-small cell (14) 14
lung neoplasms - enzymology (14) 14
membrane proteins - genetics (14) 14
membrane proteins - metabolism (14) 14
proto-oncogene proteins b-raf - genetics (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
cancer research (13) 13
gene amplification (13) 13
general & internal medicine (13) 13
phosphorylation (13) 13
proto-oncogene proteins - metabolism (13) 13
analysis (12) 12
biological sciences (12) 12
medicine, general & internal (12) 12
receptor protein-tyrosine kinases - antagonists & inhibitors (12) 12
respiratory system (12) 12
tyrosine (12) 12
chemistry (11) 11
colorectal cancer (11) 11
egfr (11) 11
hemic and lymphatic diseases (11) 11
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (438) 438
French (14) 14
German (7) 7
Korean (2) 2
Spanish (2) 2
Chinese (1) 1
Danish (1) 1
Japanese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 10/2012, Volume 13, Issue 10, pp. 1011 - 1019
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2011, Volume 12, Issue 11, pp. 1004 - 1012
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2010, Volume 363, Issue 18, pp. 1693 - 1703
A small group of patients with non–small-cell lung cancer have genetic lesions that activate anaplastic lymphoma kinase (ALK). Crizotinib, an orally... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Microtubule-Associated Proteins - genetics | Humans | Middle Aged | Receptors, Growth Factor - antagonists & inhibitors | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Protein-Tyrosine Kinases - genetics | Pyridines - adverse effects | Serine Endopeptidases - genetics | Cell Cycle Proteins - genetics | Adult | Female | Pyrazoles - adverse effects | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Pyridines - administration & dosage | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Kaplan-Meier Estimate | In Situ Hybridization, Fluorescence | Receptor Protein-Tyrosine Kinases | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Care and treatment | Lung cancer, Small cell | Genetic aspects | Diagnosis | Health aspects | Phosphotransferases | Lymphomas | Pharmaceutical industry | Lung cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 03/2012, Volume 30, Issue 8, pp. 863 - 870
Journal Article